Elevance Health Inc. (ELV) Misses Q4 EPS by 14c; offers guidance

Elevance Health Inc. (NYSE: ELV) reported Q4 EPS of $3.84, $0.14 worse than the analyst estimate of $3.98. Revenue for the quarter came in at $45 billion versus the consensus estimate of $44.9 billion.

GUIDANCE:

Elevance Health Inc. sees FY2025 EPS of $34.15-$34.85, versus the consensus of $34.86.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Faraday Future reveals robot lineup and new products at Automate